North America Veterinary Ocular Medicine Market Size, by Corticosteroids Product Classification (2024-2032)

Strategic evolution within ophthalmic therapeutics shaped North America Veterinary Ocular Medicine market performance in 2024, as branded veterinary products recorded USD 23,559.85 thousand, while generic formulations achieved USD 18,534.70 thousand, emphasizing differentiation across product portfolios. Compounded drugs and off-label human ocular solutions reached USD 7,431.08 thousand and USD 4,834.89 thousand, respectively, signaling the diversification of treatment options. In 2025, the North America Veterinary Ocular Medicine Market is estimated to maintain steady expansion, with branded and generic categories rising to USD 24,777.84 thousand and USD 19,742.70 thousand, supported by enhanced distribution efficiency and growing clinical acceptance.

From 2026 to 2032, the North America Veterinary Ocular Medicine Market reflects a strategic growth trajectory fueled by product innovation, regulatory support, and advancements in veterinary care infrastructure. Branded veterinary products are projected to reach USD 39,332.93 thousand, while compounded formulations advance to USD 13,279.76 thousand, indicating strong demand for precision-based ocular therapeutics. Increasing investment in research and professional awareness continues to strengthen the market’s value chain, ensuring sustainable profitability and long-term scalability.